Improving brain cancer treatments
Paediatric high-grade glioma (HGG)
This project focuses on improving treatment and survival for children with some of the most high-risk brain cancers.
Translating research
Sarcoma (bone & soft tissue cancer)
Clinical translation of laboratory tested CAR T cell therapy into Phase 1 trials for paediatric treatment of sarcoma.
Tackling the effects of treatment
Treatment toxicity can cause infertility
Developing genetic risk prediction of long term infertility from childhood cancer therapies leading to informed decisions and application of preventive measures.
Recovering from treatment
RECOVER – Responding to late effects in survivors of childhood cancer
Empowering young survivors of childhood cancer to transition to adulthood with the knowledge, skills and resources required to manage their ongoing health needs.
Supporting clinical trials
Providing access to international clinical trials and additional clinical trial expertise
ANZCHOG international trials set up and manage the clinical trials for bran new kids' cancer treatments, giving kids access to the very latest therapies.
Acute myeloid leukaemia (AML)
Acute myeloid leukaemia (AML)
A highly fatal blood cancer in adults and children. By adding a newly developed NAMPT inhibitor to standard of care treatment, this project can pave the way towards a more effective treatment of poor outcome adult and paediatric AML.